Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

SCN8A activates epithelial to mesenchymal transition. 3 / 3

| 1 2

➶

reach

"Knockdown of Nav1.6 significantly inhibited the proliferation, epithelial-mesenchymal transition and invasiveness of FTC cells."

35753135

➶

eidos

"Hence , we targeted the JAK-STAT pathway and demonstrated that Nav1.6 enhanced FTC cell proliferation , epithelial-mesenchymal transition , and invasion by phosphorylating JAK2 to activate STAT3 ."

35753135

➶

reach

"We therefore asked whether MED 12 KD indeed induces an EMT like process and whether the processes induced by MED12 KD are likewise associated with poor prognosis in CRC."

23178117

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...